ProMIS Neurosciences Inc - ESG Rating & Company Profile powered by AI
The SDG score for ProMIS Neurosciences Inc indicates the company's transparency towards the UN SDGs. This webpage includes a Q&A table about ProMIS Neurosciences Inc. Full Sustainability analysis of ProMIS Neurosciences Inc are reached by signing up for free.
ProMIS Neurosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 8.0, social score of 6.4 and governance score of 6.0.
6.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 294 | SMS Pharmaceuticals Ltd | 6.9 | High |
| 294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
| 314 | ProMIS Neurosciences Inc | 6.8 | High |
| 314 | Camurus AB | 6.8 | High |
| 314 | Cassiopea SpA | 6.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ProMIS Neurosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes ProMIS Neurosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes ProMIS Neurosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes ProMIS Neurosciences Inc offer flexible work?
Sign up for free to unlockDoes ProMIS Neurosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ProMIS Neurosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ProMIS Neurosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose water use targets?
Sign up for free to unlockDoes ProMIS Neurosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid ProMIS Neurosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes ProMIS Neurosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ProMIS Neurosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes ProMIS Neurosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ProMIS Neurosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ProMIS Neurosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose its waste policy?
Sign up for free to unlockDoes ProMIS Neurosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose energy use targets?
Sign up for free to unlockDoes ProMIS Neurosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ProMIS Neurosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ProMIS Neurosciences Inc
These potential risks are based on the size, segment and geographies of the company.
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.